Our manifesto for cancer drug discovery and development – focusing on innovation to tackle treatment resistance and meeting patients’ needs 30 Apr 2019 Professor Paul Workman argues that concerted action is needed to accelerate patients’ access to today’s new treatments – and incentivise creation of the innovative new medicines of tomorrow that will lead to step changes in clinical outcome. Find out more Show/Hide
More, better new drugs: five ways the system must change 04 Jan 2016 Professor Paul Workman outlines five solutions to the challenge of the broken drug system of drug discovery and development, which is failing to deliver enough innovative new cancer drugs to those who need them. Find out more Show/Hide
Disappointing week for first cancer drug targeted at an inherited genetic fault 03 Jun 2015 This week we’ve had very disappointing news that the highly innovative cancer drug, olaparib, has been turned down by NICE. This decision is harder to bear as we found out last week that the drug will not be made available to patients via the Cancer Drugs Fund. Find out more Show/Hide